MedTrace Logo

Vision Improvement for Legally Blind Dry AMD Patients

NCT04875234 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2023-03-22

No results posted yet for this study

Summary

This retrospective observational study is intended to assess the feasibility of using a nonsignificant risk device for vision improvement for legally blind dry AMD patients.

Conditions

Interventions

DEVICE

Clear-K Low Vision Aid Treatment

A Clear-K Low Vision Aid Device is used to produce small corneal shape and refraction changes in order to redirect light onto functional areas of the retina.

Sponsors & Collaborators

  • Optimal Acuity Corporation

    lead INDUSTRY

Principal Investigators

  • Michael Berry, PhD · Optimal Acuity Corporation

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2025-07-31
Completion
2026-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04875234 on ClinicalTrials.gov